Pharmafile Logo

Piramal | Healthcare

Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal | Healthcare, a part of the Piramal Enterprise. We are one of the largest custom manufacturing companies in the world that provides flexibility and scalability of operations. We have created a vast network of contract development and manufacturing facilities located in North America, Europe and Asia that offers a multitude of services that cover the entire drug-cycle, from development and commercial manufacturing to off-patent supplies of Active Pharmaceutical Ingredients (APIs) and formulations. Our network enables us to deliver benefits by strategically placing projects to take advantage of low costs, local supply chains and specific customer/ market requirements. This division features among the top 10 contract drug manufacturers in the world.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

247 Business Park, A - Wing, 6th Floor, LBS Marg, Vikhroli (West), Mumbai, Maharashtra, 400083, India
022-30956893

 Latest Content from PMHub 

Perspective on biotech

In this supplementary issue of Perspective, we reveal the emerging technologies taking the biotech world by storm and ask if the definition of a biotech organisation needs updating.

Lucid CEO discusses communication excellence in a multimedia world

“The two words 'information' and 'communication' are often used interchangeably, but they signify quite different things. Information is giving out; communication is getting through,” Sydney J. Harris, a renowned Anglo-American...

What will the NHS’s Capped Expenditure Process (CEP) mean for pharma?

Paul Midgley, Director of NHS Insight at Wilmington Healthcare, explains how pharma should tailor its approach

Why AI might be the rep’s best friend

When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...

Four Health triumphs at PM Society Digital Awards

Press Releases | September 18, 2017 | Four Agency Worldwide

This year’s PM Society Digital Awards brought smiles all round Four Health and its clients, Johnson & Johnson and Novo Nordisk, with the agencies media and communications teams walking away...

Lucid tackles Tough Mudder 2017

Last Saturday, twenty enthusiastic Lucidians took on the 2017 London South Tough Mudder Half challenge at the Holmbrush Estate in Surrey. Covering 5 miles and 13 imposing obstacles, the team...

Research Partnership has published a new Living with Ulcerative Colitis (UC) US market report for 2017

White Papers and Resources | September 6, 2017 | Inizio

Living with Ulcerative Colitis (UC) is a study conducted amongst 110 adult UC patients in the US. The study employs a mixed quantitative/qualitative methodology and is available to purchase alongside...

20 questions: Round 5

White Papers and Resources | September 6, 2017 | Inizio

As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month we asked our US employees about office life in Philadelphia.Watch the video: https://www.researchpartnership.com/news/2017/08/20-questions-round-5/

Research Partnership publishes 2017 Living with NASH report

White Papers and Resources | September 6, 2017 | Inizio

Healthcare market research and consultancy specialist Research Partnership has published a new Living with Non-alcoholic Steatohepatitis (NASH) report for 2017.Living with Non-alcoholic Steatohepatitis (NASH) is a quantitative US study conducted online amongst patients....

Blending qual and quant – the benefits of a hybrid approach

White Papers and Resources | September 6, 2017 | Inizio

My colleague Chris Gaj and I recently conducted a video dialogue on the topic of hybrid qual/quant methods in which we discussed why clients often want to blend the two, and the...